Immunopathogenesis of systemic sclerosis

Rheumatic Disease Clinics of North America

Volumn 22, Issue 4, 1996, Pages 695-708

  White, B ^a  

^a UNIVERSITY OF MARYLAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; CD4 ANTIGEN; CD8 ANTIGEN; CELL ADHESION MOLECULE; DNA TOPOISOMERASE; PROTEIN;

AGE; B LYMPHOCYTE; BASOPHIL; CELLULAR IMMUNITY; CENTROMERE; CYTOTOXICITY; EOSINOPHIL; HUMAN; HUMORAL IMMUNITY; IMMUNOPATHOGENESIS; INFLAMMATORY CELL; LUNG ALVEOLITIS; MACROPHAGE; MAST CELL; MOLECULAR MIMICRY; MONOCYTE; NATURAL KILLER CELL; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SEX DIFFERENCE; SYSTEMIC SCLEROSIS; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION;

EID: 0029963412     PISSN: 0889857X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-857X(05)70296-9     Document Type: Article

References (81)

1. D. Abraham S. Lupoli A. McWhirter Expression and function of surface antigens on scleroderma fibroblasts Arthritis Rheum 34 1991 1164
2. F. Alderuccio E.K. Chan E.M. Tan Molecular characterization of an autoantigen of PM-Scl in the polymyositis/scleroderma overlap syndrome: A unique and complete human cDNA encoding an apparent 75-kD acidic protein of the nucleolar complex J Exp Med 173 1991 841
3. W.J. Alms S.P. James F.M. Wigley Cytokine mRNAs produced spontaneously by peripheral blood mononuclear cells and bronchoalveolar lavage cells from patients with scleroderma Clin Res 40 1992 396A
4. B. Berman J. Wietzerbin Tumor necrosis factor-α (TNF-α), interferon-α (IFN-α) and interferon-γ (IFN-γ) receptors on human normal and scleroderma dermal fibroblasts in vitro J Dermatol Sci 3 1992 82
5. R.L. Bernat G.G. Borisy N.F. Rothfield Injection of anticentromeric antibodies in interphase disrupts events required for chromosome movement in mitosis J Cell Biol 111 1990 1519
6. D. Briggs C. Stephens R. Vaughan A molecular and serologic analysis of the major histocompatibility complex and complement C4 in systemic sclerosis Arthritis Rheum 36 1993 943
7. A.D. Cambrey N.K. Harrison K.E. Dawes Increased levels of endothelin-1 in bronchoalveolar lavage fluid from patients with systemic sclerosis contribute to fibroblast mitogenic activity in vitro Am J Respir Cell Mol Biol 11 1994 439
8. P. Clements J. Peter M. Agopian Elevated serum levels of soluble interleukin 2 receptor, interleukin 2 and neopterin in diffuse and limited scleroderma: Effect of chlorambucil J Rheumatol 17 1990 908
9. B. Corrin D. Butcher B.J. McAnulty Immunohistochemical localization of transforming growth factor-β1 in the lungs of patients with systemic sclerosis, cryptogenic fibrosing alveolitis, and other lung disorders Histopathology 24 1994 145
10. B. Crestani N. Seta M. De Bandt Interleukin-6 secretion by monocytes and alveolar macrophages in systemic sclerosis with lung involvement Am J Respir Crit Care Med 149 1994 1260
11. B. Crestani N. Seta E. Palazzo Interleukin-8 and neutrophils in systemic sclerosis with lung involvement Am J Resp Crit Care Med 150 1994 1363
12. S. Currie M. Saunders M. Knowles Immunologic aspects of systemic sclerosis: In vitro activity of lymphocytes from patients with the disorder Br J Dermatol 84 1970 400
13. H. Dang M.J. Dauphinee N. Talal Serum antibody to retroviral gag proteins in systemic sclerosis Arthritis Rheum 34 1991 1337
14. D. Degiannis J.R. Seibold M. Czarnecki Soluble interleukin-2 receptors in patients with systemic sclerosis. Clinical and laboratory correlations Arthritis Rheum 33 1990 375
15. W.K. Eng S.D. Pandit R. Sternglanz Mapping of the active site tyrosine of eukaryotic DNA topoisomerase I J Biol Chem 264 1989 13373
16. C.A. Feghali K.L. Bost D.W. Boulware Mechanisms of pathogenesis in scleroderma: I. Overproduction of interleukin-6 by fibroblasts cultured from affected skin sites of patients with scleroderma J Rheumatol 19 1992 1207
17. R. Fleishmajer J.S. Perlish J.R.T. Reeves Cellular infiltrates in scleroderma skin Arthritis Rheum 20 1977 975
18. Q. Ge Y. Wu E.P. Trieu Analysis of the specificity of anti-PM–Scl autoantibodies Arthritis Rheum 37 1994 1445
19. C. Gelpi M.A. Martinez S. Vidal Autoantibodies to a transfer RNA-associated protein in a murine model of chronic graft vs. host disease J Immunol 152 1994 1989
20. M.S. Gruschwitz O.P. Hornstein P. Von Den Driesch Correlation of soluble adhesion molecules in the peripheral blood of scleroderma patients with their in situ expression and with disease activity Arthritis Rheum 38 1995 184
21. M. Gruschwitz P. Von Den Driesch P. Kellner Expression of adhesion proteins involved in cell-cell and cell-matrix interactions in the skin of patients with progressive systemic sclerosis J Am Acad Dermatol 27 1992 169
22. R. Gustafsson K. Fredens O. Nettelbladt Eosinophil activation in systemic sclerosis Arthritis Rheum 34 1991 414
23. M. Hebbar P. Lassalle A. Janin E-Selectin expression in salivary endothelial cells and sera from patients with systemic sclerosis. Role of resident mast cell-derived tumor necrosis factor α Arthritis Rheum 38 1995 406
24. H. Higley K. Persichitte S. Chu Immunocytochemical localization and serologic detection of transforming growth factor β 1. Association with type I procollagen and inflammatory cell markers in diffuse and limited systemic sclerosis, morphea, and Raynaud's phenomenon Arthritis Rheum 37 1994 278
25. S. Hildebrandt E. Weiner J.L. Senecal The IgG, IgM, and IgA isotypes of anti-topoisomerase I and anticentromere antibodies Arthritis Rheum 33 1990 724
26. M. Hirakata Y. Okano U. Pati Identification of autoantibodies to RNA polymerase II. Occurrence in systemic sclerosis and association with autoantibodies to RNA polymerase I and III J Clin Invest 91 1993 2665
27. C.M. Holt N. Lindsey J. Moult Antibody-dependent cellular cytotoxicity of vascular endothelium: Characterization and pathogenic associations in systemic sclerosis Clin Exp Med 78 1989 359
28. S. Howe E.Y. Eaker J.E. Sallustio Antimyenteric neuronal antibodies in scleroderma J Clin Invest 94 1994 76
29. H. Imai M.J. Fritzler R. Neri Immunocytochemical characterization of human NOR-90 (upstream binding factor) and associated antigens reactive with autoimmune sera. Two MR forms of NOR-90/hUBF autoantigens Mol Biol Rep 19 1994 115
30. E.W. Jabs C.M. Tuck-Muller G.J. Anhalt Cytogenetic survey in systemic sclerosis: Correlation of aneuploidy with the presence of anti-centromere antibodies Cytogenet Cell Genet 63 1993 169
31. M.B. Kahaleh Endothelin, an endothelial-dependent vasoconstrictor in scleroderma: Enhanced production and profibrotic action Arthritis Rheum 34 1991 978
32. M.B. Kahaleh E.C. LeRoy Interleukin-2 in scleroderma: Correlation of serum level with extent of skin involvement and disease duration Ann Intern Med 110 1989 446
33. M.B. Kahaleh T. Yin The molecular mechanism of endothelial cell (EC) injury in scleroderma (SSc): identification of granzyme 1 (a product of cytolytic T-cell) in SSc Arthritis Rheum 33 1990 S67
34. V.-M. Kahari M. Sandberg H. Kalimo Identification of fibroblasts responsible for increased collagen production in localized scleroderma by in situ hybridization J Invest Dermatol 90 1988 664
35. T.V. Kantor D. Friberg T.A. Medsger Jr Cytokine production and serum levels in systemic sclerosis Clin Immunol Immunopathol 65 1992 278
36. K.N. Kasturi A. Hatakeyama H. Spiera Antifibrillarin autoantibodies present in systemic sclerosis and other connective tissue diseases interact with similar epitopes J Exp Med 181 1995 1027
37. Y. Kawaguchi M. Harigai M. Hara Increased interleukin-1 receptor, type I, at messenger RNA and protein level in skin fibroblasts from patients with systemic sclerosis Biochem Biophys Res Commun 184 1992 1504
38. Y. Kawaguchi M. Harigai K. Suzuki Interleukin-1 receptor on fibroblasts from systemic sclerosis patients induces excessive functional responses to interleukin 1β Biochem Biophys Res Commun 190 1993 154
39. K. Kikuchi T. Kadono H. Ihn Growth regulation in scleroderma fibroblasts: Increased response to transforming growth factor-β 1 J Invest Derm 105 1995 128
40. A.E. Koch L.B. Kronfeld-Harrington Z. Szekanecz In situ expression of cytokines and cellular adhesion molecules in the skin of patients with systemic sclerosis. Their role in early and late disease Pathobiology 61 1993 239
41. A.E. Koch M.A. Litvak J.C. Burrows Decreased monocyte-mediated angiogenesis in scleroderma Clinical Immunol Immunopathol 64 1992 153
42. M. Kulozik A. Hogg B. Lankat-Buttgereit Colocalization of transforming growth factor β2 with α1(I) procollagen mRNA in tissue sections of patients with systemic sclerosis J Clin Invest 86 1990 917
43. M. Kuwana J. Kaburaki T. Mimori Autoantibody reactive with three classes of RNA polymerases in sera from patients with systemic sclerosis J Clin Invest 91 1993 1399
44. M. Kuwana J. Kaburaki Y. Okano The HLA-DR and DQ genes control the autoimmune response to DNA topoisomerase I in systemic sclerosis (scleroderma) J Clin Invest 92 1993 1296
45. S. Lupoli P. Amlot C. Black Normal immune responses in systemic sclerosis J Rheumatol 17 1990 323
46. R.M. Marks M. Czerniecki B.S. Andrews The effects of scleroderma serum on human microvascular endothelial cells. Induction of antibody-dependent cellular cytotoxicity Arthritis Rheum 31 1988 1524
47. G.G. Maul S.A. Jimenez E. Riggs Determination of an epitope of the diffuse systemic sclerosis marker antigen DNA topoisomerase 1: Sequence similarity with retroviral p30gag protein suggests a possible cause for autoimmunity in systemic sclerosis Proc Natl Acad Sci USA 86 1989 8492
48. N.J. McHugh J. Whyte G. Harvey Anti-topoisomerase I antibodies in silica-associated systemic sclerosis Arthritis Rheum 37 1994 1198
49. Y. Misaki K. Yamamoto K. Yanagi B-cell epitope on the U1 snRNP-C autoantigen contains a sequence similar to that of the herpes simplex virus protein Eur J Immunol 23 1993 1064
50. Y. Moroi C. Peebles M.J. Fritzler Autoantibody to centromere (kinetochore) in scleroderma sera Proc Natl Acad Sci USA 77 1980 1627
51. T. Muryoi K.N. Kasturi M.J. Kafina Antitopoisomerase I monoclonal autoantibodies from scleroderma patients and tight skin mouse interact with similar epitopes J Exp Med 175 1992 1103
52. B.W. Needleman Increased expression of intercellular adhesion molecule 1 on the fibroblasts of scleroderma patients Arthritis Rheum 33 1990 1847
53. B.W. Needleman J. Choi A. Burrows-Mezu Secretion and binding of transforming growth factor-β by scleroderma and normal dermal fibroblasts Arthritis Rheum 33 1990 650
54. B.W. Needleman F.M. Wigley R.W. Stair Interleukin-1, interleukin-2, interleukin-4, interleukin-6, tumor necrosis factor α, and interferon-γ levels in sera from patients with scleroderma Arthritis Rheum 35 1992 67
55. C.V. Oddis Y. Okano W.A. Rudert Serum autoantibody to the nucleolar antigen PM-Scl. Clinical and immunogenetic associations Arthritis Rheum 35 1992 1211
56. M.R. Patrick B.W. Kirkham M. Graham Circulating interleukin 1 β and soluble interleukin-2 receptor: Evaluation as markers of disease activity in scleroderma J Rheumatol 22 1995 654
57. R.J. Prescott A.J. Freemont C.J.P. Jones Sequential dermal microvascular and perivascular changes in the development of scleroderma J Pathol 166 1992 255
58. D.W. Puett H.A. Fuchs Rapid exacerbation of scleroderma in a patient treated with interleukin-2 and lymphokine-activated killer cells for renal cell carcinoma J Rheumatol 21 1994 752
59. C.C. Query J.D. Keene A human autoimmune protein associated with U1 RNA contains a region of homology that is crossreactive with retroviral p30gag antigen Cell 51 1988 211
60. S. Reitamo A. Remitz J. Varga Demonstration of interleukin-8 and auto-antibodies to interleukin-8 in the serum of patients with systemic sclerosis and related disorders Arch Dermatol Res 129 1993 189
61. J.R. Reveille E. Durban M.J. MacLeod-St Clair Association of amino acid sequences in the HLA-DQB1 first domain with the antitopoisomerase I autoantibody response in scleroderma (progressive systemic sclerosis) J Clin Invest 90 1992 973
62. J.R. Reveille D. Owerbach R. Goldstein Association of polar amino acids at position 26 of the HLA-DQB1 first domain with the anticentromere autoantibody response in systemic sclerosis (scleroderma) J Clin Invest 89 1992 1209
63. L.I. Romero S.H. Pincus In situ localization of interleukin-6 in normal skin and atrophic cutaneous disease Int Arch Allergy Immunol 99 1992 44
64. G.A. Rossi P.B. Bitterman S.I. Rennard Evidence for chronic inflammation as a component of the interstitial lung disease associated with progressive systemic sclerosis Am Rev Respir Dis 131 1985 612
65. A.D. Roumm T.L. Whiteside T.A. Medsger Jr Lymphocytes in the skin of patients with progressive systemic sclerosis: Quantification, subtyping, and clinical correlations Arthritis Rheum 27 1984 645
66. L. Rudnicka S. Majewski M. Blasczczyk Adhesion of peripheral blood mononuclear cells to vascular endothelium in patients with systemic sclerosis (scleroderma) Arthritis Rheum 35 1992 771
67. L. Rudnicka J. Varga A.M. Christiano Elevated expression of type VII collagen in the skin of patients with systemic sclerosis. Regulation by transforming growth factor-β J Clin Invest 93 1994 1709
68. M. Satoh M. Kuwana T. Ogasawara Association of autoantibodies to topoisomerase 1 and the phosphorylated (IIO) for RNA polymerase II in Japanese scleroderma patients J Immunol 153 1994 5838
69. A. Sakamoto T. Sumida T. Maeda T cell receptor Vβ repertoire of double-negative α/β T cells in patients with systemic sclerosis Arthritis Rheum 35 1992 944
70. J.R. Seibold R.C. Giorno H.N. Clamon Dermal mast cell degranulation in systemic sclerosis Arthritis Rheum 33 1990 1702
71. X. Shi-Wen M. Panesar R. Vancheeswaran Expression and shedding of intercellular adhesion molecule 1 and lymphocyte function-associated antigen 3 by normal and scleroderma fibroblasts. Effects of interferon-γ, tumor necrosis factor-α, and estrogen Arthritis Rheum 37 1994 1689
72. P.P. Sfikakis B.K. McCune G. Tsokas Immunohistologic demonstration of transforming growth factor-β isoforms in the skin of patients with systemic sclerosis Clin Immunol Immunopathol 69 1993 199
73. R.M. Silver K.S. Miller M.B. Kinsella Evaluation and management of scleroderma lung disease using bronchoalveolar lavage Am J Med 88 1990 470
74. A. Sipos L. Czirjak G. Lorincz Studies on anti-granulocyte and anti-platelet antibodies in patients with systemic sclerosis Scand J Rheumatol 17 1988 43
75. A. Szegedi P. Boros J. Chen An Fcα RIII[CD16]-specific autoantibody from a patient with progressive systemic sclerosis Immunol Lett 35 1993 69
76. E.M. Tan G.P. Rodnan I. Garcia Diversity of antinuclear antibodies in progressive systemic sclerosis Arthritis Rheum 23 1980 617
77. B. White Immune Pathogenesis P. Clements D. Furst Systemic Sclerosis. 1996 Lea & Febiger Malvern, PA 229 250
78. B. White J.H. Korn T.H. Piela-Smith Preferential adherence of human γ/δ, CD8+ and memory T cells to fibroblasts J Immunol 152 1994 4912
79. A. Yamakage K. Kikuchi E.A. Smith Selective upregulation of platelet-derived growth factor α receptors by transforming growth factor β in scleroderma fibroblasts J Exp Med 175 1992 1227
80. V.V. Yurovsky F.M. Wigley R.A. Wise Skewing of the CD8+ T cell repertoire in the lungs of systemic sclerosis patients Hum Immunol 48 1996 84
81. V.V. Yurovsky P.A. Sutton D.H. Schulze Expansion of selected Vδ1+γ/δ T cells in systemic sclerosis patients J Immunol 153 1994 881